4.7 Article

Analysis of Worsening Heart Failure Events in an Integrated Health Care System

期刊

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2022.04.045

关键词

clinic visit; emergency department; heart failure; outpatient; worsening

资金

  1. Novartis AG
  2. Kaiser Permanente Northern California Community Benefit Program
  3. Mentored Patient -Oriented Research Career Development Award [K23HL15015 9]
  4. Amarin Pharma
  5. Abbott
  6. Novartis
  7. National Heart, Lung, and Blood Institute
  8. National Institute of Diabetes, Digestive and Kidney Diseases
  9. Na- tional Institute on Aging
  10. Amarin Pharma Inc
  11. Janssen Research and Development
  12. CSL Behring

向作者/读者索取更多资源

The study aims to describe the incidence of worsening heart failure (WHF) events across the care continuum from ambulatory encounters to hospitalizations.
BACKGROUND There is growing interest to disentangle worsening heart failure (WHF) from location of care and move away from hospitalization as a surrogate for acuity. OBJECTIVES The purpose of this study was to describe the incidence of WHF events across the care continuum from ambulatory encounters to hospitalizations. METHODS We studied calendar year cohorts of adults with diagnosed heart failure (HF) from 2010-2019 within a large, integrated health care delivery system. Electronic health record (EHR) data were accessed for outpatient encounters, emergency department (ED) visits/observation stays, and hospitalizations. WHF was defined as >= 1 symptom, >= 2 objective findings including >= 1 sign, and >= 1 change in HF-related therapy. Symptoms and signs were ascertained using natural language processing. RESULTS We identified 103,138 eligible individuals with mean age 73.6 +/- 13.7 years, 47.5% women, and mean left ventricular ejection fraction of 51.4% +/- 13.7%. There were 1,136,750 unique encounters including 743,039 (65.4%) outpatient encounters, 224,670 (19.8%) ED visits/observation stays, and 169,041 (14.9%) hospitalizations. A total of 126,008 WHF episodes were identified, including 34,758 (27.6%) outpatient encounters, 28,301 (22.5%) ED visits/ observation stays, and 62,949 (50.0%) hospitalizations. The annual incidence (events per 100 person-years) of WHF increased from 25 to 33 during the study period primarily caused by outpatient encounters (7 to 10) and ED visits/ observation stays (4 to 7). The 30-day rate of hospitalizations for WHF ranged from 8.2% for outpatient encounters to 12.4% for hospitalizations. CONCLUSIONS ED visits/observation stays and outpatient encounters account for approximately one-half of WHF events, are driving the underlying growth in HF morbidity, and portend a poor short-term prognosis. (C) 2022 by the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据